Cholinergic elements in a human choriocarcinoma cell line

Michael Fant, Kermit V Speeg, Sandra Harper, Raymond D. Harbison

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Components of the cholinergic system have been identified in the JEG choriocarcinoma cell line. [3H]Quinuclidinyl benzilate (QNB) was used to identify high affinity muscarinic binding sites in a whole cell preparation. Specific binding was saturable with respect to QNB concentration and revealed a binding site density of 27 fmoles/mg protein. The bimolecular rates of association, 2.24 × 107 M-1 min-1, and dissociation, 4.2 × 10-3min-1, revealed a dissociation constant (Kd) of 180 pM which agreed closely with that derived from saturation isotherms, 245 pM. Muscarinic antagonists and agonists were able to compete effectively for these binding sites, whereas non-muscarinic compounds were not. Cholinesterase activity was also demonstrated with substrate preference consistent with that of acetyl-cholinesterase (acetylcholine > acetyl-β-methylcholine > butyrylcholine) hydrolyzing 2.42 ± 0.19 × 10-3 μmoles acetylcholine·min-1 ·(mg protein)-1. No choline acetyltransferase activity was detected in these cells, however.

Original languageEnglish (US)
Pages (from-to)967-970
Number of pages4
JournalBiochemical Pharmacology
Volume30
Issue number9
DOIs
StatePublished - May 1 1981
Externally publishedYes

Fingerprint

Choriocarcinoma
Quinuclidinyl Benzilate
Cholinergic Agents
Binding Sites
Cholinesterases
Cells
Cell Line
Muscarinic Agonists
Muscarinic Antagonists
Choline O-Acetyltransferase
Acetylcholine
Isotherms
Proteins
Association reactions
Substrates

ASJC Scopus subject areas

  • Pharmacology

Cite this

Cholinergic elements in a human choriocarcinoma cell line. / Fant, Michael; Speeg, Kermit V; Harper, Sandra; Harbison, Raymond D.

In: Biochemical Pharmacology, Vol. 30, No. 9, 01.05.1981, p. 967-970.

Research output: Contribution to journalArticle

Fant, Michael ; Speeg, Kermit V ; Harper, Sandra ; Harbison, Raymond D. / Cholinergic elements in a human choriocarcinoma cell line. In: Biochemical Pharmacology. 1981 ; Vol. 30, No. 9. pp. 967-970.
@article{557bf446f02541bc844dafdeac64da16,
title = "Cholinergic elements in a human choriocarcinoma cell line",
abstract = "Components of the cholinergic system have been identified in the JEG choriocarcinoma cell line. [3H]Quinuclidinyl benzilate (QNB) was used to identify high affinity muscarinic binding sites in a whole cell preparation. Specific binding was saturable with respect to QNB concentration and revealed a binding site density of 27 fmoles/mg protein. The bimolecular rates of association, 2.24 × 107 M-1 min-1, and dissociation, 4.2 × 10-3min-1, revealed a dissociation constant (Kd) of 180 pM which agreed closely with that derived from saturation isotherms, 245 pM. Muscarinic antagonists and agonists were able to compete effectively for these binding sites, whereas non-muscarinic compounds were not. Cholinesterase activity was also demonstrated with substrate preference consistent with that of acetyl-cholinesterase (acetylcholine > acetyl-β-methylcholine > butyrylcholine) hydrolyzing 2.42 ± 0.19 × 10-3 μmoles acetylcholine·min-1 ·(mg protein)-1. No choline acetyltransferase activity was detected in these cells, however.",
author = "Michael Fant and Speeg, {Kermit V} and Sandra Harper and Harbison, {Raymond D.}",
year = "1981",
month = "5",
day = "1",
doi = "10.1016/0006-2952(81)90041-1",
language = "English (US)",
volume = "30",
pages = "967--970",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Cholinergic elements in a human choriocarcinoma cell line

AU - Fant, Michael

AU - Speeg, Kermit V

AU - Harper, Sandra

AU - Harbison, Raymond D.

PY - 1981/5/1

Y1 - 1981/5/1

N2 - Components of the cholinergic system have been identified in the JEG choriocarcinoma cell line. [3H]Quinuclidinyl benzilate (QNB) was used to identify high affinity muscarinic binding sites in a whole cell preparation. Specific binding was saturable with respect to QNB concentration and revealed a binding site density of 27 fmoles/mg protein. The bimolecular rates of association, 2.24 × 107 M-1 min-1, and dissociation, 4.2 × 10-3min-1, revealed a dissociation constant (Kd) of 180 pM which agreed closely with that derived from saturation isotherms, 245 pM. Muscarinic antagonists and agonists were able to compete effectively for these binding sites, whereas non-muscarinic compounds were not. Cholinesterase activity was also demonstrated with substrate preference consistent with that of acetyl-cholinesterase (acetylcholine > acetyl-β-methylcholine > butyrylcholine) hydrolyzing 2.42 ± 0.19 × 10-3 μmoles acetylcholine·min-1 ·(mg protein)-1. No choline acetyltransferase activity was detected in these cells, however.

AB - Components of the cholinergic system have been identified in the JEG choriocarcinoma cell line. [3H]Quinuclidinyl benzilate (QNB) was used to identify high affinity muscarinic binding sites in a whole cell preparation. Specific binding was saturable with respect to QNB concentration and revealed a binding site density of 27 fmoles/mg protein. The bimolecular rates of association, 2.24 × 107 M-1 min-1, and dissociation, 4.2 × 10-3min-1, revealed a dissociation constant (Kd) of 180 pM which agreed closely with that derived from saturation isotherms, 245 pM. Muscarinic antagonists and agonists were able to compete effectively for these binding sites, whereas non-muscarinic compounds were not. Cholinesterase activity was also demonstrated with substrate preference consistent with that of acetyl-cholinesterase (acetylcholine > acetyl-β-methylcholine > butyrylcholine) hydrolyzing 2.42 ± 0.19 × 10-3 μmoles acetylcholine·min-1 ·(mg protein)-1. No choline acetyltransferase activity was detected in these cells, however.

UR - http://www.scopus.com/inward/record.url?scp=0019423805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019423805&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(81)90041-1

DO - 10.1016/0006-2952(81)90041-1

M3 - Article

C2 - 7195203

AN - SCOPUS:0019423805

VL - 30

SP - 967

EP - 970

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 9

ER -